Mark C. Schiller - 15 Jan 2024 Form 3 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Chief Legal Officer
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
15 Jan 2024
Net transactions value
$0
Form type
3
Filing time
17 Jan 2024, 17:09:43 UTC
Next filing
26 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KZR Common Stock 39,695 15 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 50,000 $2.28 Direct F2
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 25,000 $2.28 Direct F2
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 52,500 $2.28 Direct F2
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 110,000 $2.28 Direct F3
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 130,000 $2.28 Direct F4
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 165,000 $2.28 Direct F5
holding KZR Employee Stock Option (right to buy) 15 Jan 2024 Common Stock 250,000 $0.9300 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,000 restricted stock units ("RSUs"). The RSUs will vest in two equal installments on July 2, 2024 and July 2, 2025, subject to the Reporting Person continuing to provide service through each such date.
F2 Fully vested and exercisable.
F3 One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.
F4 One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date.
F5 One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date.
F6 One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 7, 2024, subject to the Reporting Person continuing to provide service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney